Skip to main content
Earnings Labs
Longeveron Inc. logo

Longeveron Inc. (LGVN)

NASDAQ·Healthcare·Biotechnology

$1.77

+2.89%

Mkt Cap $20.02M

Analyst Ratings

Buy

1

Hold

1

Sell

0

Price Target (1 analysts)

$10.00

Range $10.00 – $10.00

Implied Upside

+465.0%

Consensus $10.00 vs current $1.77